Literature DB >> 14599863

Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines.

C Bethan Powell1, Philip Fung, Jim Jackson, Joe Dall'Era, Debra Lewkowicz, Isaac Cohen, Karen Smith-McCune.   

Abstract

OBJECTIVES: Given the increasingly common use of complementary medicine in cancer patients, we tested the in vitro cytotoxicity of aqueous extracts of 15 traditional Chinese herbs with purported anticancer properties on ovarian and breast cancer cell lines.
METHODS: Cell viability after treatment with herbal extract was measured by metabolism of a tetrazolium substrate. Apoptosis was measured by nuclear and DNA fragmentation and Annexin V binding.
RESULTS: One herb, Herba Scutellaria barbatae, was cytotoxic to 100% (11 of 11) of actively proliferating ovarian lines tested and 50% (2 of 4) of actively proliferating breast cell lines tested. Confluent cultures were resistant to killing by herb, whereas subconfluent cultures were sensitive. Resistant proliferating cell lines expressed higher levels of bcl2. Transfection of the most sensitive ovarian cancer cell line (A2780) with bcl2 resulted in a noticeable protection against apoptosis, but there was no protection in other transfected lines.
CONCLUSIONS: These results will be useful in guiding future studies of herbal aqueous extracts, as well as providing information for clinicians when patients are concurrently using these herbs along with conventional cancer therapies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599863     DOI: 10.1016/j.ygyno.2003.07.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

Review 1.  Anticancer effects of Chinese herbal medicine, science or myth?

Authors:  Wen-jing Ruan; Mao-de Lai; Jian-guang Zhou
Journal:  J Zhejiang Univ Sci B       Date:  2006-12       Impact factor: 3.066

2.  Successful treatment of canine open cervix-pyometra with Yun-Nan-Pai-Yao, a Chinese herbal preparation.

Authors:  B Salgado; R Paramo; H Sumano
Journal:  Vet Res Commun       Date:  2007-05       Impact factor: 2.459

Review 3.  Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.

Authors:  Dana M Chase; Steven J Gibson; Daniele A Sumner; Jennifer W Bea; David S Alberts
Journal:  Curr Treat Options Oncol       Date:  2014-03

4.  PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice.

Authors:  Yao Chen; Ling Wang; Hao Liu; Fahuan Song; Caiyun Xu; Kai Zhang; Qing Chen; Shuang Wu; Yunqi Zhu; Ying Dong; Min Zhou; Hong Zhang; Mei Tian
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

5.  The anticancer effects of Resina Draconis extract on cholangiocarcinoma.

Authors:  Feng Wen; Xiangxuan Zhao; Yun Zhao; Zaiming Lu; Qiyong Guo
Journal:  Tumour Biol       Date:  2016-09-28

6.  Induction of apoptosis in HeLa cells by chloroform fraction of seed extracts of Nigella sativa.

Authors:  Gowhar Shafi; Anjana Munshi; Tarique N Hasan; Ali A Alshatwi; A Jyothy; David K Y Lei
Journal:  Cancer Cell Int       Date:  2009-11-27       Impact factor: 5.722

7.  Evaluation of antiproliferative and anti-inflammatory activities of methanol extract and its fractions from the Mediterranean sponge.

Authors:  Afef Dellai; Monia Deghrigue; Audrey Laroche-Clary; Hedi Ben Masour; Nabil Chouchane; Jacques Robert; Abderrahman Bouraoui
Journal:  Cancer Cell Int       Date:  2012-05-15       Impact factor: 5.722

Review 8.  A new dawn for the use of traditional Chinese medicine in cancer therapy.

Authors:  Harendra S Parekh; Gang Liu; Ming Q Wei
Journal:  Mol Cancer       Date:  2009-03-20       Impact factor: 27.401

9.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-06       Impact factor: 3.677

10.  Eurycomanone induce apoptosis in HepG2 cells via up-regulation of p53.

Authors:  Yusmazura Zakaria; Asmah Rahmat; Azimahtol Hawariah Lope Pihie; Noor Rain Abdullah; Peter J Houghton
Journal:  Cancer Cell Int       Date:  2009-06-10       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.